Back to Search
DEVIN TULLY, PHARMD
PHARMD
Pharmacy
NPI: 1417633678Individual
Specialties, Licenses & Credentials
PharmacyPrimary
Pharmacy
Code: 333600000X
23050(AL)
Research & Publications (20)
Unravelling selection shifts among foot-and-mouth disease virus (FMDV) serotypes.
PMID 19455214·Evol Bioinform Online·2007
8-other
Gene expression profiling in liver and testis of rats to characterize the toxicity of triazole fungicides.
PMID 16643972·Toxicol Appl Pharmacol·2006
7-preclinical
Effects of arsenic, cadmium, chromium, and lead on gene expression regulated by a battery of 13 different promoters in recombinant HepG2 cells.
PMID 11032763·Toxicol Appl Pharmacol·2000
8-other
A comparative study of HIV-1 clade C env evolution in a Zambian infant with an infected rhesus macaque during disease progression.
PMID 19609201·AIDS·2009
4-observational
Active site conformational changes of prostasin provide a new mechanism of protease regulation by divalent cations.
PMID 19388054·Protein Sci·2009
8-other
Camostat attenuates airway epithelial sodium channel function in vivo through the inhibition of a channel-activating protease.
PMID 19190233·J Pharmacol Exp Ther·2009
7-preclinical
Shifts in the selection-drift balance drive the evolution and epidemiology of foot-and-mouth disease virus.
PMID 19004952·J Virol·2009
7-preclinical
The tale of a modern animal plague: tracing the evolutionary history and determining the time-scale for foot and mouth disease virus.
PMID 18945462·Virology·2008
7-preclinical
Discovery of inhibitors of the channel-activating protease prostasin (CAP1/PRSS8) utilizing structure-based design.
PMID 18752942·Bioorg Med Chem Lett·2008
8-other
A study of the coevolutionary patterns operating within the env gene of the HIV-1 group M subtypes.
PMID 17921487·Mol Biol Evol·2007
8-other
Induction of cytochrome P450 enzymes in rat liver by two conazoles, myclobutanil and triadimefon.
PMID 17484520·Xenobiotica·2007
7-preclinical
Synthesis and SAR of succinamide peptidomimetic inhibitors of cathepsin S.
PMID 17382545·Bioorg Med Chem Lett·2007
7-preclinical
Arylaminoethyl carbamates as a novel series of potent and selective cathepsin S inhibitors.
PMID 16876407·Bioorg Med Chem Lett·2006
7-preclinical
Synthesis and SAR of arylaminoethyl amides as noncovalent inhibitors of cathepsin S: P3 cyclic ethers.
PMID 16876402·Bioorg Med Chem Lett·2006
7-preclinical
Gene expression profiling in the liver of CD-1 mice to characterize the hepatotoxicity of triazole fungicides.
PMID 16730040·Toxicol Appl Pharmacol·2006
7-preclinical
Synthesis and evaluation of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 3: heterocyclic P3.
PMID 16446091·Bioorg Med Chem Lett·2006
7-preclinical
Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: Optimization of P1 and N-aryl.
PMID 16412634·Bioorg Med Chem Lett·2006
8-other
Fluconazole-induced hepatic cytochrome P450 gene expression and enzymatic activities in rats and mice.
PMID 16406388·Toxicol Lett·2006
7-preclinical
Design and synthesis of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 1.
PMID 16183279·Bioorg Med Chem Lett·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 700 19TH ST S
BIRMINGHAM, AL 35233 - Phone
- (205) 933-8101
Quick Facts
- NPI
- 1417633678
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile